Pediatric low-grade glioma in the era of molecular diagnostics

S Ryall, U Tabori, C Hawkins - Acta neuropathologica communications, 2020 - Springer
Low grade gliomas are the most frequent brain tumors in children and encompass a
spectrum of histologic entities which are currently assigned World Health Organisation …

CRISPR/cas systems redefine nucleic acid detection: principles and methods

M Wang, R Zhang, J Li - Biosensors and Bioelectronics, 2020 - Elsevier
Methods that enable rapid, sensitive and specific analyses of nucleic acid sequences have
positive effects on precise disease diagnostics and effective clinical treatments by providing …

Genomes for kids: the scope of pathogenic mutations in pediatric cancer revealed by comprehensive DNA and RNA sequencing

S Newman, J Nakitandwe, CA Kesserwan… - Cancer …, 2021 - aacrjournals.org
Genomic studies of pediatric cancer have primarily focused on specific tumor types or high-
risk disease. Here, we used a three-platform sequencing approach, including whole …

[HTML][HTML] Integrated molecular and clinical analysis of 1,000 pediatric low-grade gliomas

S Ryall, M Zapotocky, K Fukuoka, L Nobre, AG Stucklin… - Cancer cell, 2020 - cell.com
Pediatric low-grade gliomas (pLGG) are frequently driven by genetic alterations in the RAS-
mitogen-activated protein kinase (RAS/MAPK) pathway yet show unexplained variability in …

[HTML][HTML] Application of next generation sequencing in laboratory medicine

Y Zhong, F Xu, J Wu, J Schubert… - Annals of laboratory …, 2021 - synapse.koreamed.org
The rapid development of next-generation sequencing (NGS) technology, including
advances in sequencing chemistry, sequencing technologies, bioinformatics, and data …

How I treat relapsed acute lymphoblastic leukemia in the pediatric population

SP Hunger, EA Raetz - Blood, The Journal of the American …, 2020 - ashpublications.org
Relapsed acute lymphoblastic leukemia (ALL) has remained challenging to treat in children,
with survival rates lagging well behind those observed at initial diagnosis. Although there …

[HTML][HTML] The future of precision oncology

SL Rulten, RP Grose, SA Gatz, JL Jones… - International Journal of …, 2023 - mdpi.com
Our understanding of the molecular mechanisms underlying cancer development and
evolution have evolved rapidly over recent years, and the variation from one patient to …

Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network

GD Demetri, CR Antonescu, B Bjerkehagen… - Annals of oncology, 2020 - Elsevier
Highlights•NTRK gene fusions are oncogenic drivers in a variety of tumor types including
adult and pediatric sarcomas.•TRK inhibitors provide effective treatment options for patients …

Fusion oncogenes are associated with increased metastatic capacity and persistent disease in pediatric thyroid cancers

AT Franco, JC Ricarte-Filho, A Isaza… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE In 2014, data from a comprehensive multiplatform analysis of 496 adult papillary
thyroid cancer samples reported by The Cancer Genome Atlas project suggested that …

[HTML][HTML] Targeting DNA damage response and repair to enhance therapeutic index in cisplatin-based cancer treatment

RC Kiss, F **a, S Acklin - International journal of molecular sciences, 2021 - mdpi.com
Platinum-based chemotherapies, such as cisplatin, play a large role in cancer treatment.
The development of resistance and treatment toxicity creates substantial barriers to disease …